Rockefeller Capital Management
NEOS

Rockefeller Capital Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Rockefeller Capital Management’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-578
Closed – – 3082
2020
Q3 		$0 Hold
578
– – ﹤0.01% 2906
2020
Q2 		$0 Hold
578
– – ﹤0.01% 2743
2020
Q1 		$0 Hold
578
– – ﹤0.01% 2537
2019
Q4 		$1K Hold
578
– – ﹤0.01% 2023
2019
Q3 		$1K Buy
+578
New +$935 ﹤0.01% 1892

Other funds holding NEOS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rockefeller Capital Management's NEOS Position: Q4 2020 in Review

Rockefeller Capital Management sold out of Neos Therapeutics, Inc (NEOS) in Q4 2020, closing a stake of 578 shares.

Rockefeller Capital Management first reported a position in NEOS in Q3 2019 and held it in 5 quarters. The position peaked at $1K in Q4 2019. 37 funds tracked by Wall St. Rank hold NEOS as of Q4 2020.

  • Rockefeller Capital Management reported no remaining Neos Therapeutics, Inc position as of Q4 2020 after selling out during the quarter.
  • Rockefeller Capital Management sold 578 Neos Therapeutics, Inc shares in Q4 2020.
  • Rockefeller Capital Management first reported a position in Neos Therapeutics, Inc in Q3 2019 and held it in 5 quarters.
  • Rockefeller Capital Management's Neos Therapeutics, Inc position peaked at $1K in Q4 2019.
  • 37 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2020.

Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.